Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
CM.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.43EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.43EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.122.3 (Delta)EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
AY.122.3 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.132 (Delta)EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
AY.132 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.160.17EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-3870.9South Korea
B.1.160.17EWon-ECACACAATCGATGCGCAGTA20502636526346R-4838.81South Korea
BA.4.1.10EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.4.1.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.19EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.19EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KF.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
KF.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FK.1.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FK.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2.7.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.2.7.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.8.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.8.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EU.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
EU.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.14EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.14EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.21EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.21EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GK.11EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
GK.11EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CJ.1.3.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
CJ.1.3.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XANEWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
XANEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.1.4.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
BN.1.4.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DV.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
DV.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CS.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
CS.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.83EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.83EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BJ.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BJ.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDGEWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XDGEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GA.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
GA.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KD.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
KD.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XCSEWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used